Loading…

Clinicopathological Parameters and Immunohistochemical Profiles in Correlation with MRI Characteristics in Glioblastomas

Glioblastoma is considered the most aggressive tumor of the central nervous system. The tumor microenvironment includes several components, such as endothelial cells, immune cells, and extracellular matrix components like matrix metalloproteinase-9 (MMP-9), which facilitates the proliferation of end...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2024-12, Vol.25 (23), p.13043
Main Authors: Sipos, Tamás-Csaba, Attila, Kövecsi, Kocsis, Lóránd, Bălașa, Adrian, Chinezu, Rareș, Baróti, Beáta Ágota, Pap, Zsuzsánna
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 23
container_start_page 13043
container_title International journal of molecular sciences
container_volume 25
creator Sipos, Tamás-Csaba
Attila, Kövecsi
Kocsis, Lóránd
Bălașa, Adrian
Chinezu, Rareș
Baróti, Beáta Ágota
Pap, Zsuzsánna
description Glioblastoma is considered the most aggressive tumor of the central nervous system. The tumor microenvironment includes several components, such as endothelial cells, immune cells, and extracellular matrix components like matrix metalloproteinase-9 (MMP-9), which facilitates the proliferation of endothelial cells with pro-angiogenic roles. The MRI characteristics of glioblastomas can contribute to determining the prognosis. The aim of this study was to analyze the relationship between tumor angiogenesis in glioblastomas in association with MMP-9 immunoexpression. The results were correlated with the Ki-67 proliferation index, p53 immunoexpression, and the mutational status of and , as well as MRI imaging data. This retrospective study included forty-four patients diagnosed with glioblastoma at the Department of Pathology, Târgu Mureș County Emergency Clinical Hospital. MMP-9 immunoexpression was observed in approximately half of the cases, more frequently in patients over 65 years old. Comparing the imaging data with the immunohistochemical results, we observed that the median tumor volume was higher in glioblastomas with and p53 mutations, wild-type status, negative MMP-9 expression, and high Ki-67 proliferation indexes. The median values of MVD-CD34 and MVD-CD105 were higher in cases with extensive peritumoral edema in the contralateral hemisphere. Additionally, mutations were frequently associated with a more pronounced deviation of the median structures. To statistically validate the associations between MRI and the histopathological features of glioblastomas, further studies with larger cohorts are required.
doi_str_mv 10.3390/ijms252313043
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_3146915814</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A819951032</galeid><sourcerecordid>A819951032</sourcerecordid><originalsourceid>FETCH-LOGICAL-g275t-59d3fbeedf31fdaf53433dc7ef668a92a1a4b55a0f43c2fb67330437f15b84303</originalsourceid><addsrcrecordid>eNptkU1v1DAQhi0EoqVw5IoiceGyxfbYSXysIigrFYEQnKNJYm-88sdiJyr8exxaxIeQD-PDM8-MXxPynNFLAEVf26PPXHJgQAU8IOdMcL6jtG4e_nE_I09yPlLKgUv1mJyBqlvRSHFOvnXOBjvGEy5zdPFgR3TVR0zo9aJTrjBM1d77NcTZ5iWOs_Z3SIrGOp0rG6oupqQdLjaG6tYuc_X-077q5iIZi6O02fEnd-1sHBwWjcf8lDwy6LJ-dl8vyJe3bz5373Y3H6733dXN7sAbueykmsAMWk8GmJnQSBAA09hoU9ctKo4MxSAlUiNg5GaoG9iCaAyTQyuAwgV5dec9pfh11Xnpvc2jdg6DjmvugYlaMdkyUdCX_6DHuKZQttsowRSXTfObOqDTvQ0mLuWhm7S_aplSklHghbr8D1XOtAUYg97S-7vhxf3wdfB66k_Jekzf-19fBT8A2SeWCg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3144192577</pqid></control><display><type>article</type><title>Clinicopathological Parameters and Immunohistochemical Profiles in Correlation with MRI Characteristics in Glioblastomas</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Sipos, Tamás-Csaba ; Attila, Kövecsi ; Kocsis, Lóránd ; Bălașa, Adrian ; Chinezu, Rareș ; Baróti, Beáta Ágota ; Pap, Zsuzsánna</creator><creatorcontrib>Sipos, Tamás-Csaba ; Attila, Kövecsi ; Kocsis, Lóránd ; Bălașa, Adrian ; Chinezu, Rareș ; Baróti, Beáta Ágota ; Pap, Zsuzsánna</creatorcontrib><description>Glioblastoma is considered the most aggressive tumor of the central nervous system. The tumor microenvironment includes several components, such as endothelial cells, immune cells, and extracellular matrix components like matrix metalloproteinase-9 (MMP-9), which facilitates the proliferation of endothelial cells with pro-angiogenic roles. The MRI characteristics of glioblastomas can contribute to determining the prognosis. The aim of this study was to analyze the relationship between tumor angiogenesis in glioblastomas in association with MMP-9 immunoexpression. The results were correlated with the Ki-67 proliferation index, p53 immunoexpression, and the mutational status of and , as well as MRI imaging data. This retrospective study included forty-four patients diagnosed with glioblastoma at the Department of Pathology, Târgu Mureș County Emergency Clinical Hospital. MMP-9 immunoexpression was observed in approximately half of the cases, more frequently in patients over 65 years old. Comparing the imaging data with the immunohistochemical results, we observed that the median tumor volume was higher in glioblastomas with and p53 mutations, wild-type status, negative MMP-9 expression, and high Ki-67 proliferation indexes. The median values of MVD-CD34 and MVD-CD105 were higher in cases with extensive peritumoral edema in the contralateral hemisphere. Additionally, mutations were frequently associated with a more pronounced deviation of the median structures. To statistically validate the associations between MRI and the histopathological features of glioblastomas, further studies with larger cohorts are required.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms252313043</identifier><identifier>PMID: 39684754</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adult ; Age ; Aged ; Aged, 80 and over ; Analysis ; Angiogenesis ; Biomarkers, Tumor - metabolism ; Brain Neoplasms - diagnostic imaging ; Brain Neoplasms - genetics ; Brain Neoplasms - metabolism ; Brain Neoplasms - pathology ; Care and treatment ; Development and progression ; Diagnosis ; Edema ; Endothelium ; Evaluation ; Extracellular matrix ; Female ; Gender ; Glioblastoma - diagnostic imaging ; Glioblastoma - genetics ; Glioblastoma - metabolism ; Glioblastoma - pathology ; Glioblastoma multiforme ; Glioma ; Gliomas ; Health aspects ; Humans ; Immunohistochemistry ; Isocitrate Dehydrogenase - genetics ; Isocitrate Dehydrogenase - metabolism ; Ki-67 Antigen - genetics ; Ki-67 Antigen - metabolism ; Localization ; Magnetic resonance imaging ; Magnetic Resonance Imaging - methods ; Male ; Matrix Metalloproteinase 9 - genetics ; Matrix Metalloproteinase 9 - metabolism ; Medical prognosis ; Medical research ; Medicine, Experimental ; Middle Aged ; Mutation ; Neovascularization, Pathologic - diagnostic imaging ; Neovascularization, Pathologic - genetics ; Neovascularization, Pathologic - metabolism ; Patients ; Permeability ; Prognosis ; Retrospective Studies ; Tumor proteins ; Tumor Suppressor Protein p53 - genetics ; Tumor Suppressor Protein p53 - metabolism ; Tumors ; Vascular endothelial growth factor ; X-linked Nuclear Protein - genetics ; X-linked Nuclear Protein - metabolism</subject><ispartof>International journal of molecular sciences, 2024-12, Vol.25 (23), p.13043</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0009-0003-2249-3918 ; 0000-0001-8875-0874 ; 0000-0002-2529-2818 ; 0000-0002-6368-0555</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3144192577/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3144192577?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39684754$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sipos, Tamás-Csaba</creatorcontrib><creatorcontrib>Attila, Kövecsi</creatorcontrib><creatorcontrib>Kocsis, Lóránd</creatorcontrib><creatorcontrib>Bălașa, Adrian</creatorcontrib><creatorcontrib>Chinezu, Rareș</creatorcontrib><creatorcontrib>Baróti, Beáta Ágota</creatorcontrib><creatorcontrib>Pap, Zsuzsánna</creatorcontrib><title>Clinicopathological Parameters and Immunohistochemical Profiles in Correlation with MRI Characteristics in Glioblastomas</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Glioblastoma is considered the most aggressive tumor of the central nervous system. The tumor microenvironment includes several components, such as endothelial cells, immune cells, and extracellular matrix components like matrix metalloproteinase-9 (MMP-9), which facilitates the proliferation of endothelial cells with pro-angiogenic roles. The MRI characteristics of glioblastomas can contribute to determining the prognosis. The aim of this study was to analyze the relationship between tumor angiogenesis in glioblastomas in association with MMP-9 immunoexpression. The results were correlated with the Ki-67 proliferation index, p53 immunoexpression, and the mutational status of and , as well as MRI imaging data. This retrospective study included forty-four patients diagnosed with glioblastoma at the Department of Pathology, Târgu Mureș County Emergency Clinical Hospital. MMP-9 immunoexpression was observed in approximately half of the cases, more frequently in patients over 65 years old. Comparing the imaging data with the immunohistochemical results, we observed that the median tumor volume was higher in glioblastomas with and p53 mutations, wild-type status, negative MMP-9 expression, and high Ki-67 proliferation indexes. The median values of MVD-CD34 and MVD-CD105 were higher in cases with extensive peritumoral edema in the contralateral hemisphere. Additionally, mutations were frequently associated with a more pronounced deviation of the median structures. To statistically validate the associations between MRI and the histopathological features of glioblastomas, further studies with larger cohorts are required.</description><subject>Adult</subject><subject>Age</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis</subject><subject>Angiogenesis</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Brain Neoplasms - diagnostic imaging</subject><subject>Brain Neoplasms - genetics</subject><subject>Brain Neoplasms - metabolism</subject><subject>Brain Neoplasms - pathology</subject><subject>Care and treatment</subject><subject>Development and progression</subject><subject>Diagnosis</subject><subject>Edema</subject><subject>Endothelium</subject><subject>Evaluation</subject><subject>Extracellular matrix</subject><subject>Female</subject><subject>Gender</subject><subject>Glioblastoma - diagnostic imaging</subject><subject>Glioblastoma - genetics</subject><subject>Glioblastoma - metabolism</subject><subject>Glioblastoma - pathology</subject><subject>Glioblastoma multiforme</subject><subject>Glioma</subject><subject>Gliomas</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Isocitrate Dehydrogenase - genetics</subject><subject>Isocitrate Dehydrogenase - metabolism</subject><subject>Ki-67 Antigen - genetics</subject><subject>Ki-67 Antigen - metabolism</subject><subject>Localization</subject><subject>Magnetic resonance imaging</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Male</subject><subject>Matrix Metalloproteinase 9 - genetics</subject><subject>Matrix Metalloproteinase 9 - metabolism</subject><subject>Medical prognosis</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Neovascularization, Pathologic - diagnostic imaging</subject><subject>Neovascularization, Pathologic - genetics</subject><subject>Neovascularization, Pathologic - metabolism</subject><subject>Patients</subject><subject>Permeability</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Tumor proteins</subject><subject>Tumor Suppressor Protein p53 - genetics</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><subject>Tumors</subject><subject>Vascular endothelial growth factor</subject><subject>X-linked Nuclear Protein - genetics</subject><subject>X-linked Nuclear Protein - metabolism</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkU1v1DAQhi0EoqVw5IoiceGyxfbYSXysIigrFYEQnKNJYm-88sdiJyr8exxaxIeQD-PDM8-MXxPynNFLAEVf26PPXHJgQAU8IOdMcL6jtG4e_nE_I09yPlLKgUv1mJyBqlvRSHFOvnXOBjvGEy5zdPFgR3TVR0zo9aJTrjBM1d77NcTZ5iWOs_Z3SIrGOp0rG6oupqQdLjaG6tYuc_X-077q5iIZi6O02fEnd-1sHBwWjcf8lDwy6LJ-dl8vyJe3bz5373Y3H6733dXN7sAbueykmsAMWk8GmJnQSBAA09hoU9ctKo4MxSAlUiNg5GaoG9iCaAyTQyuAwgV5dec9pfh11Xnpvc2jdg6DjmvugYlaMdkyUdCX_6DHuKZQttsowRSXTfObOqDTvQ0mLuWhm7S_aplSklHghbr8D1XOtAUYg97S-7vhxf3wdfB66k_Jekzf-19fBT8A2SeWCg</recordid><startdate>20241201</startdate><enddate>20241201</enddate><creator>Sipos, Tamás-Csaba</creator><creator>Attila, Kövecsi</creator><creator>Kocsis, Lóránd</creator><creator>Bălașa, Adrian</creator><creator>Chinezu, Rareș</creator><creator>Baróti, Beáta Ágota</creator><creator>Pap, Zsuzsánna</creator><general>MDPI AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0003-2249-3918</orcidid><orcidid>https://orcid.org/0000-0001-8875-0874</orcidid><orcidid>https://orcid.org/0000-0002-2529-2818</orcidid><orcidid>https://orcid.org/0000-0002-6368-0555</orcidid></search><sort><creationdate>20241201</creationdate><title>Clinicopathological Parameters and Immunohistochemical Profiles in Correlation with MRI Characteristics in Glioblastomas</title><author>Sipos, Tamás-Csaba ; Attila, Kövecsi ; Kocsis, Lóránd ; Bălașa, Adrian ; Chinezu, Rareș ; Baróti, Beáta Ágota ; Pap, Zsuzsánna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g275t-59d3fbeedf31fdaf53433dc7ef668a92a1a4b55a0f43c2fb67330437f15b84303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Age</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis</topic><topic>Angiogenesis</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Brain Neoplasms - diagnostic imaging</topic><topic>Brain Neoplasms - genetics</topic><topic>Brain Neoplasms - metabolism</topic><topic>Brain Neoplasms - pathology</topic><topic>Care and treatment</topic><topic>Development and progression</topic><topic>Diagnosis</topic><topic>Edema</topic><topic>Endothelium</topic><topic>Evaluation</topic><topic>Extracellular matrix</topic><topic>Female</topic><topic>Gender</topic><topic>Glioblastoma - diagnostic imaging</topic><topic>Glioblastoma - genetics</topic><topic>Glioblastoma - metabolism</topic><topic>Glioblastoma - pathology</topic><topic>Glioblastoma multiforme</topic><topic>Glioma</topic><topic>Gliomas</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Isocitrate Dehydrogenase - genetics</topic><topic>Isocitrate Dehydrogenase - metabolism</topic><topic>Ki-67 Antigen - genetics</topic><topic>Ki-67 Antigen - metabolism</topic><topic>Localization</topic><topic>Magnetic resonance imaging</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Male</topic><topic>Matrix Metalloproteinase 9 - genetics</topic><topic>Matrix Metalloproteinase 9 - metabolism</topic><topic>Medical prognosis</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Neovascularization, Pathologic - diagnostic imaging</topic><topic>Neovascularization, Pathologic - genetics</topic><topic>Neovascularization, Pathologic - metabolism</topic><topic>Patients</topic><topic>Permeability</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Tumor proteins</topic><topic>Tumor Suppressor Protein p53 - genetics</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><topic>Tumors</topic><topic>Vascular endothelial growth factor</topic><topic>X-linked Nuclear Protein - genetics</topic><topic>X-linked Nuclear Protein - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sipos, Tamás-Csaba</creatorcontrib><creatorcontrib>Attila, Kövecsi</creatorcontrib><creatorcontrib>Kocsis, Lóránd</creatorcontrib><creatorcontrib>Bălașa, Adrian</creatorcontrib><creatorcontrib>Chinezu, Rareș</creatorcontrib><creatorcontrib>Baróti, Beáta Ágota</creatorcontrib><creatorcontrib>Pap, Zsuzsánna</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sipos, Tamás-Csaba</au><au>Attila, Kövecsi</au><au>Kocsis, Lóránd</au><au>Bălașa, Adrian</au><au>Chinezu, Rareș</au><au>Baróti, Beáta Ágota</au><au>Pap, Zsuzsánna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinicopathological Parameters and Immunohistochemical Profiles in Correlation with MRI Characteristics in Glioblastomas</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2024-12-01</date><risdate>2024</risdate><volume>25</volume><issue>23</issue><spage>13043</spage><pages>13043-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Glioblastoma is considered the most aggressive tumor of the central nervous system. The tumor microenvironment includes several components, such as endothelial cells, immune cells, and extracellular matrix components like matrix metalloproteinase-9 (MMP-9), which facilitates the proliferation of endothelial cells with pro-angiogenic roles. The MRI characteristics of glioblastomas can contribute to determining the prognosis. The aim of this study was to analyze the relationship between tumor angiogenesis in glioblastomas in association with MMP-9 immunoexpression. The results were correlated with the Ki-67 proliferation index, p53 immunoexpression, and the mutational status of and , as well as MRI imaging data. This retrospective study included forty-four patients diagnosed with glioblastoma at the Department of Pathology, Târgu Mureș County Emergency Clinical Hospital. MMP-9 immunoexpression was observed in approximately half of the cases, more frequently in patients over 65 years old. Comparing the imaging data with the immunohistochemical results, we observed that the median tumor volume was higher in glioblastomas with and p53 mutations, wild-type status, negative MMP-9 expression, and high Ki-67 proliferation indexes. The median values of MVD-CD34 and MVD-CD105 were higher in cases with extensive peritumoral edema in the contralateral hemisphere. Additionally, mutations were frequently associated with a more pronounced deviation of the median structures. To statistically validate the associations between MRI and the histopathological features of glioblastomas, further studies with larger cohorts are required.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>39684754</pmid><doi>10.3390/ijms252313043</doi><orcidid>https://orcid.org/0009-0003-2249-3918</orcidid><orcidid>https://orcid.org/0000-0001-8875-0874</orcidid><orcidid>https://orcid.org/0000-0002-2529-2818</orcidid><orcidid>https://orcid.org/0000-0002-6368-0555</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2024-12, Vol.25 (23), p.13043
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_proquest_miscellaneous_3146915814
source Publicly Available Content Database; PubMed Central
subjects Adult
Age
Aged
Aged, 80 and over
Analysis
Angiogenesis
Biomarkers, Tumor - metabolism
Brain Neoplasms - diagnostic imaging
Brain Neoplasms - genetics
Brain Neoplasms - metabolism
Brain Neoplasms - pathology
Care and treatment
Development and progression
Diagnosis
Edema
Endothelium
Evaluation
Extracellular matrix
Female
Gender
Glioblastoma - diagnostic imaging
Glioblastoma - genetics
Glioblastoma - metabolism
Glioblastoma - pathology
Glioblastoma multiforme
Glioma
Gliomas
Health aspects
Humans
Immunohistochemistry
Isocitrate Dehydrogenase - genetics
Isocitrate Dehydrogenase - metabolism
Ki-67 Antigen - genetics
Ki-67 Antigen - metabolism
Localization
Magnetic resonance imaging
Magnetic Resonance Imaging - methods
Male
Matrix Metalloproteinase 9 - genetics
Matrix Metalloproteinase 9 - metabolism
Medical prognosis
Medical research
Medicine, Experimental
Middle Aged
Mutation
Neovascularization, Pathologic - diagnostic imaging
Neovascularization, Pathologic - genetics
Neovascularization, Pathologic - metabolism
Patients
Permeability
Prognosis
Retrospective Studies
Tumor proteins
Tumor Suppressor Protein p53 - genetics
Tumor Suppressor Protein p53 - metabolism
Tumors
Vascular endothelial growth factor
X-linked Nuclear Protein - genetics
X-linked Nuclear Protein - metabolism
title Clinicopathological Parameters and Immunohistochemical Profiles in Correlation with MRI Characteristics in Glioblastomas
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T20%3A21%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinicopathological%20Parameters%20and%20Immunohistochemical%20Profiles%20in%20Correlation%20with%20MRI%20Characteristics%20in%20Glioblastomas&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Sipos,%20Tam%C3%A1s-Csaba&rft.date=2024-12-01&rft.volume=25&rft.issue=23&rft.spage=13043&rft.pages=13043-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms252313043&rft_dat=%3Cgale_proqu%3EA819951032%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g275t-59d3fbeedf31fdaf53433dc7ef668a92a1a4b55a0f43c2fb67330437f15b84303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3144192577&rft_id=info:pmid/39684754&rft_galeid=A819951032&rfr_iscdi=true